Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples